-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Zymeworks, Raises Price Target to $44

Benzinga·11/11/2026 18:26:02
Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $39 to $44.